Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ZGN-433
ZGN-433
Zafgen Announces Cardiovascular Data from Phase 1b Study of ZGN-433 in Obesity at American Diabetes Association Annual Meeting
Enhanced Online News
Sat, 06/25/11 - 11:25 am
Zafgen
ZGN-433
obesity
weight loss
'Promising' new drug to fight fat on the horizon
The New Age
Sun, 01/16/11 - 11:40 am
Zafgen
obesity
ZGN-433